Visit Philips in booth # 1711 to see how you can bring together the power of evolving knowledge bases, genomics leaders and your own data

About IntelliSpace Genomics


At AMP 2016, we will display the IntelliSpace Genomics Platform that offers an integrated, secure, traceable, auditable, environment for hospital labs to add and streamline NGS within their molecular pathology offerings. The end-to-end platform adheres to medical software standards and provides pathologists the ability to generate genomics insights relevant to the patient’s clinical context through an easy-to-use and collaborative workflow.

About Philips


Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The Company leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The Company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. The Company’s health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries. 

Corporate Workshop

Dr. Fallon

Dr. Fallon


Dr. Dimitrova

Dr. Dimitrova


Philips IntelliSpace Genomics NGS Data Analysis Platform


by: Dr. John Fallon Chairman and Professor of Pathology, New York Medical College & Dr. Nevenka Dimitrova CTO, Philips Genomics


When: Wednesday, November 9, 2016 1:00 - 1:50 pm (EST) Charlotte Convention Center, Room 209/210

Evening Event


Philips’ Evening Reception

6-9 PM, Wednesday, November 9, 2016

The Westin Charlotte, Providence Ballroom I

601 S College St, Charlotte, NC 28202

To RSVP please email us at

Scientific Posters


Poster Number: S31, Saturday, November 12, 9:45am – 10:45am

Category: Solid Tumors

Abstract Title: Validation of an Amplicon-based NGS Cancer Panel and informatics pipeline as potential replacement for Sanger and PCR-based methods for somatic mutation detection in a hospital clinical laboratory


Poster Number: S124, Friday, November 11, 2:30pm – 3:30pm

Category: Solid Tumors

Abstract Title: Genomic Mutational Analysis of Colorectal Adenocarcinoma in Patients under the Age of 40


Poster Number: I33, Saturday, November 12, 9:45am – 10:45am

Category: Informatics

Abstract Title: Molecular Subtyping Using Un-Supervised Machine Learning Methods with Application to Renal Cell Carcinoma TCGA Data Sets

To RSVP please email us at